ABF GMBH
10/08/2018
ABF GMBH
1. Phase 1 biomarker research
15,000
10/08/2018
report 2/11/2019
2. Identify meaningful biomarkers that properly distinguish between nicotine product use groups
2/12/19. on A9 1,187,546. on A14. 1,460,780. on A15 (future) 1,460,780
no report